There was a statistically significant difference in the value of the prolactin level depending on the drug used in the therapy (χ2 = 21.098; p = 0.002), i.e., oral risperidone most often led to symptomatic and asymptomatic hyperprolactinemia. This evidence concerns the gene PRL and hyperprolactinemia.